← Eichor
Study identifier: NCT06252662 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies

Condition: Breast Cancer  ·  Sponsor: United States Naval Medical Center, Portsmouth

PhasePhase 4
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Perform a comparison of effective pain relief duration between liposomal bupivacaine and dexmedetomidine when added to bupivacaine in a block for mastectomy for cancer surgery. The erector spinae plane block is a well-established block that is utilized for post operative pain control for procedures performed on the soft tissue of the chest and chest wall as well as intrathoracic procedures. The goal is comparison of the effective duration of both study groups to determine if there is a significant difference in time and amount of post operative opioids required which admitted to hospital.

This description comes directly from the study's public registry record.

Talk to the study team

Grant A Miller, DO  ·  757-953-3238  ·  grant.a.miller7.mil@health.mil

Trevor O Elam, MD  ·  757-953-3238  ·  trevor.o.elam.mil@health.mil

Always discuss trial participation with your own doctor first.

Locations (1)

Naval Medical Center PortsmouthPortsmouth, Virginia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06252662